ATE442146T1 - Pharmazeutische zusammensetzung mit prostaglandin - Google Patents

Pharmazeutische zusammensetzung mit prostaglandin

Info

Publication number: ATE442146T1
Authority: AT; Austria
Prior art keywords: prostaglandin; pharmaceutical composition; composition containing; water; containing prostaglandin
Prior art date: 2003-11-07

Application number

AT04818172T

Other languages

English (en)

Inventor

Yusuke Sakai

Akira Ohtori

Original Assignee

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-11-07

Filing date

2004-10-26

Publication date

2009-09-15

2004-10-26 Application filed by Senju Pharma Co filed Critical Senju Pharma Co

2009-09-15 Application granted granted Critical

2009-09-15 Publication of ATE442146T1 publication Critical patent/ATE442146T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
150000003180 prostaglandins Chemical class 0.000 title 1
PXGPLTODNUVGFL-BRIYLRKRSA-N (E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC=CCCCC(O)=O PXGPLTODNUVGFL-BRIYLRKRSA-N 0.000 abstract 3
230000015556 catabolic process Effects 0.000 abstract 1
238000006731 degradation reaction Methods 0.000 abstract 1
150000004667 medium chain fatty acids Chemical class 0.000 abstract 1
239000007764 o/w emulsion Substances 0.000 abstract 1
UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
229920003169 water-soluble polymer Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT04818172T 2003-11-07 2004-10-26 Pharmazeutische zusammensetzung mit prostaglandin ATE442146T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003378196		2003-11-07
PCT/JP2004/015828 WO2005044276A1 (ja)	2003-11-07	2004-10-26	プロスタグランジン含有医薬組成物

Publications (1)

Publication Number	Publication Date
ATE442146T1 true ATE442146T1 (de)	2009-09-15

Family

ID=34567167

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04818172T ATE442146T1 (de)	2003-11-07	2004-10-26	Pharmazeutische zusammensetzung mit prostaglandin

Country Status (10)

Country	Link
US (2)	US20080139652A1 (de)
EP (1)	EP1681059B1 (de)
JP (1)	JP4762718B2 (de)
KR (1)	KR101091461B1 (de)
CN (1)	CN100484528C (de)
AT (1)	ATE442146T1 (de)
DE (1)	DE602004023106D1 (de)
ES (1)	ES2331313T3 (de)
PL (1)	PL1681059T3 (de)
WO (1)	WO2005044276A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1827373B1 (de)	2004-11-09	2008-12-03	Novagali Pharma SA	Prostaglandine enthaltende ophthalmische emulsionen
CN2811736Y (zh)	2005-03-31	2006-08-30	新灯源科技有限公司	具高散热效率的高功率发光二极管照明设备
EP1916002B1 (de) *	2005-08-02	2014-03-05	Santen Pharmaceutical Co., Ltd.	Verfahren zur prävention der zersetzung einer thermisch instabilen substanz
CA2850858A1 (en) *	2005-09-16	2007-04-05	Allergan, Inc.	Compositions and methods for the intraocular transport of therapeutic agents
DE602006016628D1 (de)	2005-10-10	2010-10-14	Novagali Pharma Sa	Prostaglandine enthaltende ophthalmische emulsionen
JPWO2007105691A1 (ja) *	2006-03-13	2009-07-30	株式会社アールテック・ウエノ	水性組成物
DE102006049091A1 (de) *	2006-10-18	2008-04-24	Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh	Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl
JPWO2008096804A1 (ja)	2007-02-07	2010-05-27	テイカ製薬株式会社	ラタノプロスト含有点眼剤
EP1985298A1 (de) *	2007-04-24	2008-10-29	Azad Pharma AG	Prostaglandinhaltige Öl-in-Wasser-Emulsionen für das Auge
FR2916636B1 (fr) *	2007-05-29	2009-09-04	Octalia Technologies	Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
JPWO2009004873A1 (ja) *	2007-06-29	2010-08-26	大正製薬株式会社	プロスタグランジン誘導体含有水性液剤
JP2009073788A (ja) *	2007-09-21	2009-04-09	Teika Seiyaku Kk	イソプロピルウノプロストン含有眼用組成物
TW201010708A (en) *	2008-06-02	2010-03-16	Intervet Int Bv	Composition comprising an antibiotic and a corticosteroid
FR2938757B1 (fr) *	2008-11-27	2010-12-31	Octalia Technologies	Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
EP2228058A1 (de)	2009-03-04	2010-09-15	Novagali Pharma S.A.	Anionische Öl-in-Wasser-Emulsion mit Prostaglandinen und Verwendungen dafür
US20130011354A1 (en) *	2009-11-09	2013-01-10	Allergan, Inc.	Compositions For Enhancing Hair Growth
NZ628266A (en)	2009-11-09	2016-02-26	Allergan Inc	Compositions and methods for stimulating hair growth
EP2389939A1 (de)	2010-05-28	2011-11-30	Novagali Pharma S.A.	Verwendung von Prostaglandinen F2alpha und Analoga zur Heilung von Horn- und Bindehautläsionen
IT1404931B1 (it) *	2010-06-11	2013-12-09	Medivis S R L	Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
JP2014515383A (ja) *	2011-05-27	2014-06-30	レイショファームゲゼルシャフトミットベシュレンクテルハフツング	ＰＧＦ２α類似体を含む眼科用製剤
US9278132B2 (en) *	2012-02-13	2016-03-08	Bausch & Lomb Incorporated	Ophthalmic pharmaceutical compositions and methods of making and using same
AU2014216112B2 (en)	2013-02-15	2019-02-21	Allergan, Inc.	Sustained drug delivery implant
JP7044714B2 (ja)	2016-11-17	2022-03-30	千寿製薬株式会社	乳剤点眼液
KR20200035047A (ko) *	2017-08-03	2020-04-01	산텐 세이야꾸 가부시키가이샤	클로르헥시딘을 함유하는 의약 조성물
KR102365008B1 (ko) *	2020-06-23	2022-02-23	주식회사태준제약	디쿠아포솔을 포함하는 점안 조성물
CN115463088A (zh) *	2021-06-11	2022-12-13	温士顿医药股份有限公司	含前列腺素衍生物的眼用纳米乳剂组合物
JP2025528009A (ja)	2022-07-15	2025-08-26	ドーシ，プラフル	医薬品と薬剤などの不安定な構成要素の安定剤とを含むコンタクトレンズを作製及び使用する方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2714065A1 (de) *	1977-03-30	1978-10-12	Boehringer Mannheim Gmbh	Instillationszubereitung
JPS6051105A (ja) *	1983-08-30	1985-03-22	Green Cross Corp:The	プロスタグランジン脂肪乳剤
CA1324129C (en)	1987-04-30	1993-11-09	Ryuzo Ueno	Prostaglandins of the f series
US4839371A (en) *	1987-09-17	1989-06-13	Smithkline Beckman Corporation	3-aralkyl-2-mercaptoyridines as dopamine-β-hydroxylase inhibitors
GB2209939B (en) *	1987-09-18	1992-01-02	R Tech Ueno Ltd	The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
US5192535A (en)	1988-02-08	1993-03-09	Insite Vision Incorporated	Ophthalmic suspensions
JP2597629B2 (ja)	1988-02-26	1997-04-09	株式会社上野製薬応用研究所	１３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US5296504A (en) *	1988-09-06	1994-03-22	Kabi Pharmacia	Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ES2317964T5 (es) *	1988-09-06	2015-02-20	Pfizer Health Ab	Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular
JPH0710833A (ja)	1991-04-16	1995-01-13	Yutaka Mizushima	プロスタグランジン類縁体、その脂肪乳剤およびその用途
US5352708A (en)	1992-09-21	1994-10-04	Allergan, Inc.	Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US5510383A (en) *	1993-08-03	1996-04-23	Alcon Laboratories, Inc.	Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension
US5631287A (en)	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US5767153A (en) *	1995-06-07	1998-06-16	Insite Vision Incorporated	Sustained release emulsions
US5767135A (en) *	1995-12-29	1998-06-16	Fernandez-Pol; Jose Alberto	Antiviral agent
US6066671A (en) *	1997-12-19	2000-05-23	Alcon Laboratories, Inc.	Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides
JP4421699B2 (ja)	1999-06-30	2010-02-24	大洋薬品工業株式会社	静脈注射可能なプロスタグランジン脂肪乳剤
US20020013294A1 (en) *	2000-03-31	2002-01-31	Delong Mitchell Anthony	Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
EP1321144B1 (de) *	2000-09-13	2010-12-08	Santen Pharmaceutical Co., Ltd.	Augentropfen
JP3876355B2 (ja)	2000-09-13	2007-01-31	参天製薬株式会社	点眼液
US6635654B1 (en) *	2003-01-09	2003-10-21	Allergan, Inc.	Ophthalmic compositions containing loratadine

2004
- 2004-10-26 DE DE602004023106T patent/DE602004023106D1/de not_active Expired - Lifetime
- 2004-10-26 ES ES04818172T patent/ES2331313T3/es not_active Expired - Lifetime
- 2004-10-26 KR KR1020067010544A patent/KR101091461B1/ko not_active Expired - Fee Related
- 2004-10-26 WO PCT/JP2004/015828 patent/WO2005044276A1/ja not_active Ceased
- 2004-10-26 AT AT04818172T patent/ATE442146T1/de not_active IP Right Cessation
- 2004-10-26 US US10/573,191 patent/US20080139652A1/en not_active Abandoned
- 2004-10-26 JP JP2005515261A patent/JP4762718B2/ja not_active Expired - Fee Related
- 2004-10-26 PL PL04818172T patent/PL1681059T3/pl unknown
- 2004-10-26 EP EP04818172A patent/EP1681059B1/de not_active Expired - Lifetime
- 2004-10-26 CN CNB2004800315504A patent/CN100484528C/zh not_active Expired - Fee Related
2011
- 2011-08-10 US US13/206,784 patent/US8697751B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE602004023106D1 (de)	2009-10-22
EP1681059A4 (de)	2007-10-10
CN1871014A (zh)	2006-11-29
KR20060123215A (ko)	2006-12-01
EP1681059B1 (de)	2009-09-09
ES2331313T3 (es)	2009-12-29
JPWO2005044276A1 (ja)	2007-05-17
JP4762718B2 (ja)	2011-08-31
EP1681059A1 (de)	2006-07-19
CN100484528C (zh)	2009-05-06
US8697751B2 (en)	2014-04-15
PL1681059T3 (pl)	2010-01-29
WO2005044276A1 (ja)	2005-05-19
KR101091461B1 (ko)	2011-12-07
US20080139652A1 (en)	2008-06-12
US20110294880A1 (en)	2011-12-01

Legal Events

Date	Code	Title	Description
2010-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE442146T1 (de)	2009-09-15	Pharmazeutische zusammensetzung mit prostaglandin
EA200801602A1 (ru)	2009-02-27	Эмульсия
KR890011586A (ko)	1989-08-21	지용성물질의 수용액
BRPI0416877A (pt)	2007-02-06	método para reduzir odor de fezes de um animal doméstico
AR032200A1 (es)	2003-10-29	Productos antitranspirantes
AR113749A1 (es)	2020-06-10	Formulaciones cannabinoides sintéticas y a base de plantas de inicio rápido y acción prolongada
CL2011000462A1 (es)	2011-06-24	Composicion de aceite que contiene aceite y caldo, en que la proporcion de aceite a caldo varia desde 1:1 hasta 1:3; metodo de preparacion de dicha composicion; uso de dicha composicion; y metodo para la preparacion de productos a base de carne que contienen aceite.
UY31633A1 (es)	2009-09-30	Plaguicidas mesoiónicos
ATE469641T1 (de)	2010-06-15	Pharmazeutische formulierung mit statinmikrokapseln in alkylestern mehrfach ungesättigter fettsäuren
EP1543811A4 (de)	2008-10-08	L-in-wasser-emulsionszusammensetzung mit teilchen
AR011846A1 (es)	2000-09-13	Una composicion farmaceutica, y el procedimiento para prepararla
AR067944A1 (es)	2009-10-28	Compuesto que comprende un aceite que contiene acidos grasos poliinsaturados de cadena larga y lecitina
EA201201380A1 (ru)	2013-04-30	Термически стабильные эмульсии "масло-в-воде", содержащие масло, которое содержит полиненасыщенные жирные кислоты
ATE532499T1 (de)	2011-11-15	Parfümzusammensetzung mit reduziertem alkoholgehalt
BRPI0413845A (pt)	2006-10-24	antioxidante que é baseado em ácido ascórbico, uso do antioxidante, e, preparação de gordura alimentìcia ou óleo alimentìcio
BRPI0418330A (pt)	2007-05-02	composições sólidas de drogas de solubilidade baixa e poloxámeros
EA200600528A1 (ru)	2006-08-25	Способ получения водорастворимых дитерпенов и их применение
CH700328B8 (de)	2010-10-15	O/W-Emulsion zur Pflege der Hand.
PT1249230E (pt)	2004-03-31	Pre-concentrados de microemulsao e microemulsoes que contem coenzima q10 sua preparacao e utilizacao
AR120027A1 (es)	2022-01-26	Emulsión de aceite en agua que comprende proteína vegetal
MA29481B1 (fr)	2008-05-02	Derives d'azolopyridine-2-one en tant qu'inhibiteurs de lipase et de phospholipase
MX2012010935A (es)	2012-12-10	Formulacion acuosa estable mejorada de (e)-4-carboxiestiril-4-clor obencil sulfona.
WO2008013669A3 (en)	2008-12-04	Alpha hydroxy acid sustained release formulation
EA200800148A1 (ru)	2008-06-30	Применение фуллерена с60 в качестве стабилизатора масел
ATE405292T1 (de)	2008-09-15	Injektierbare wässrige paclitaxel-lösungen und verfahren zu ihrer herstellung